BDSX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $27.72

Market Cap (MRQ) $292M

P/E (TTM) -4.6

EPS (TTM) $-6.03

Revenue (TTM) $103M

ROE (TTM) -540.0%

Debt/Equity -0.0

52W Range $5–$32

BDSX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1

Ex-date	Split	Type
Sept. 15, 2025	1-for-20	Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$88M

2019-12-31 → 2025-12-31

EPS$-4.67

2021-12-31 → 2025-12-31

Free Cash Flow$-24M

2020-12-31 → 2025-12-31

Net margin-27.0%

2020-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	BDSX	5Y avg	Peer Median	Verdict
P/E (TTM)	-4.65Y avg ≈-32.0	≈-32.0	·	·
P/S (TTM)	2.85Y avg ≈57.7	≈57.7	2.3	Fair value
P/B (MRQ)	32.05Y avg ≈260.4	≈260.4	3.0	Overvalued
EV / EBITDA	-7.55Y avg ≈-72.6	≈-72.6	·	·
Price / FCF (TTM)	-14.45Y avg ≈-69.3	≈-69.3	·	·
Price / Cash Flow (TTM)	-14.75Y avg ≈-88.7	≈-88.7	·	·
EV / Revenue	2.45Y avg ≈57.1	≈57.1	·	·
EV / FCF	-8.95Y avg ≈-68.5	≈-68.5	·	·
Price / Tangible Book (MRQ)	47.4	·	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	BDSX	5Y avg	Peer Median	Verdict
Operating Margin (TTM)	-20.0%5Y avg ≈-74.3%	≈-74.3%	-8.3%	Weak
EBITDA Margin	-31.5%5Y avg ≈-74.3%	≈-74.3%	-8.3%	Weak
Net Profit Margin (TTM)	-27.0%5Y avg ≈-91.3%	≈-91.3%	-11.9%	Weak
ROA (TTM)	-30.3%5Y avg ≈-51.5%	≈-51.5%	0.70%	Weak
ROE (TTM)	-540.0%5Y avg ≈166.1%	≈166.1%	10.9%	Top tier

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	BDSX	5Y avg	Peer Median	Verdict
Debt / Equity	-0.05Y avg ≈0.0	≈0.0	0.0	Low debt
Current Ratio (MRQ)	2.85Y avg ≈1.9	≈1.9	1.0	Strong liquidity
Quick Ratio	1.65Y avg ≈1.7	≈1.7	0.8	Strong liquidity
Interest Coverage	-3.65Y avg ≈-5.5	≈-5.5	·	·

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	BDSX	5Y avg	Peer Median	Verdict
Revenue YoY	24.1%5Y avg ≈17.5%	≈17.5%	·	·
Revenue CAGR 3Y	32.3%5Y avg ≈14.7%	≈14.7%	·	·
Revenue CAGR 5Y	14.2%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	BDSX	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-4.675Y avg ≈$-3.02	≈$-3.02	·	·
Revenue / Share	$11.725Y avg ≈$3.44	≈$3.44	·	·
Cash Flow / Share	$-3.085Y avg ≈$-1.20	≈$-1.20	·	·
Cash / Share	$2.305Y avg ≈$0.87	≈$0.87	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	BDSX	5Y avg	Peer Median	Verdict
Asset Turnover	1.05Y avg ≈0.6	≈0.6	1.0	Weak
Receivables Turnover	10.05Y avg ≈8.2	≈8.2	10.7	Weak
Revenue / Employee	≈$265.0K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 14.2%

Next Report Nov 02, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 5, 2026	$-0.71	$-0.92	22.9%
March 31, 2026	May 11, 2026	$-0.81	$-1.12	27.5%
Dec. 31, 2025		$-0.49	$-0.87	43.8%
Sept. 30, 2025		$-1.16	$-1.47	21.0%
June 30, 2025		$-1.60	$-1.39	-14.8%
March 31, 2025		$-1.60	$-1.39	-15.3%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 14

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue	$88M	$71M	$49M	$38M	$55M	$46M	$25M
R&D Expense	$12M	$10M	$10M	$13M	$13M	$11M	$10M
SG&A Expense	$88M	$80M	$67M	$61M	$51M	$35M	$31M
Operating Expenses	$116M	$106M	$90M	$89M	$95M	$68M	$51M
Operating Income	$-28M	$-34M	$-41M	$-51M	$-41M	$-23M	$-27M
Interest Expense	$8M	$8M	$10M	$8M	$5M	$8M	$3M
Other Non-op	$-7M	$-8M	$-11M	$-15M	$-2M	$-8M	$-4M
Income Tax	$0	$0	$0	$0	$0	$0	·
Net Income	$-35M	$-43M	$-52M	$-65M	$-43M	$-65M	$-31M
EPS (Basic)	$-4.67	$-6.64	$-0.64	$-1.55	$-1.58	·	·
EPS (Diluted)	$-4.67	$-6.64	$-0.64	$-1.55	$-1.58	·	·
Shares (Basic)	7,551,000	6,470,000	82,113,000	42,103,000	27,365,000	·	·
Shares (Diluted)	7,551,000	6,470,000	82,113,000	42,103,000	27,365,000	·	·
EBITDA	$-28M	$-34M	$-41M	$-51M	$-41M	$-23M	·

Balance Sheet 26

Metric	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$19M	$26M	$26M	$43M	$33M	$62M	$5M
Receivables	$9M	$9M	$8M	$5M	$4M	$15M	$5M
Other Current Assets	$4M	$5M	$6M	$5M	$7M	$9M	$2M
Current Assets	$33M	$39M	$40M	$53M	$44M	$86M	$13M
PP&E (Net)	$25M	$28M	$28M	$6M	$4M	$3M	$2M
PP&E (Gross)	$37M	$37M	$33M	$13M	$11M	$10M	$9M
Accum. Depreciation	$13M	$9M	$6M	$7M	$7M	$7M	$6M
Goodwill	$15M	$15M	$15M	$15M	$15M	$15M	$15M
Intangibles	$4M	$6M	$8M	$10M	$12M	$13M	$15M
Other Non-current Assets	$8M	$7M	$7M	$6M	$2M	$3M	$90.0K
Total Assets	$87M	$97M	$99M	$93M	$76M	$121M	$45M
Accounts Payable	$3M	$2M	$3M	$2M	$2M	$9M	$2M
Accrued Liabilities	$11M	$10M	$8M	$8M	$8M	$8M	$4M
Short-term Debt	$6.0K	$21.0K	$51.0K	$49.0K	$19.0K	$12M	$12M
Current Liabilities	$17M	$14M	$33M	$23M	$29M	$32M	$23M
Capital Leases	$24M	$25M	$25M	$5M	·	·	·
Other Non-current Liabilities	$1M	$815.0K	$712.0K	$558.0K	$1M	$2M	$358.0K
Total Liabilities	$90M	$76M	$95M	$72M	$56M	$80M	$76M
Long-term Debt	$50M	$40M	$40M	$30M	$10M	$28M	·
Total Debt	$6.0K	$21.0K	$51.0K	$49.0K	$19.0K	$12M	·
Common Stock	$8.0K	$7.0K	$96.0K	$78.0K	$31.0K	$27.0K	$1.0K
Paid-in Capital	$495M	$483M	$424M	$388M	$322M	$300M	$2M
Retained Earnings	$-498M	$-462M	$-420M	$-367M	$-302M	$-259M	$-227M
Stockholders' Equity	$-2M	$21M	$5M	$21M	$20M	$41M	$-225M
Liabilities + Equity	$87M	$97M	$99M	$93M	$76M	$121M	$45M
Shares Outstanding	8,253,053	7,274,578	96,235,883	77,614,358	30,789,649	26,561,504	254,918

Cash Flow 12

Metric	2025	2024	2023	2022	2021	2020	2019
D&A	$6M	$6M	$3M	$4M	$3M	$3M	$3M
Stock-based Comp	$4M	$7M	$5M	$6M	$5M	$4M	$170.0K
Amort. of Intangibles	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Operating Cash Flow	$-23M	$-49M	$-23M	$-45M	$-28M	$-21M	$-22M
CapEx	$259.0K	$3M	$23M	$3M	$2M	$2M	$1M
Investing Cash Flow	$-403.0K	$-3M	$-23M	$-4M	$-3M	$-3M	$-2M
Net Debt Issued	$-21.0K	$-51.0K	$-49.0K	$-29M	$-45M	·	·
Stock Issued	$7M	$56M	$28M	$60M	$16M	·	·
Net Stock Activity	$7M	$56M	$28M	$60M	$16M	·	·
Financing Cash Flow	$16M	$52M	$29M	$59M	$1M	$81M	$23M
Net Change in Cash	$-7M	$-39.0K	$-17M	$10M	$-30M	$57M	$-626.0K
Free Cash Flow	$-24M	$-52M	$-46M	$-48M	$-30M	$-23M	·

Profitability 5

Metric	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-31.5%	-48.4%	-84.2%	-132.4%	-75.1%	-50.3%	·
Net Margin	-39.9%	-60.2%	-106.2%	-171.3%	-79.2%	-68.8%	·
EBITDA Margin	-31.5%	-48.4%	-84.2%	-132.4%	-75.1%	-50.3%	·
ROA	-38.2%	-43.7%	-54.3%	-77.5%	-43.8%	-37.8%	·
ROE	5315.0%	-176.2%	-3327.8%	-739.4%	-241.4%	29.8%	·

Liquidity & Solvency 4

Metric	2025	2024	2023	2022	2021	2020	2019
Current Ratio	1.9	2.8	1.2	2.3	1.5	2.7	·
Quick Ratio	1.6	2.4	1.0	2.1	1.3	2.4	·
Debt / Equity	-0.0	0.0	0.0	0.0	0.0	0.3	·
Interest Coverage	-3.6	-4.2	-4.3	-6.3	-9.1	-3.0	·

Efficiency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		1.0	0.7	0.5	0.5	0.6	0.5	·
Receivables Turnover		10.0	8.8	7.7	8.8	5.7	4.4	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$-0.30	$0.14	$0.05	$0.27	$0.64	$1.55	·
Revenue / Share	$11.72	$0.55	$0.60	$0.91	·	·	·
Cash Flow / Share	$-3.08	$-0.38	$-0.28	$-1.07	·	·	·
Cash / Share	$2.30	$0.18	$0.27	$0.56	$1.06	$2.34	·
EPS (TTM)	$-4.67	$-6.64	$-0.64	$-1.55	$-1.58	·	·

Growth Rates 3

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	24.1%	45.3%	28.5%	-29.9%	19.6%	·	·
Revenue CAGR 3Y	32.3%	9.4%	2.5%	·	·	·	·
Revenue CAGR 5Y	14.2%	·	·	·	·	·	·

Valuation (TTM) 14

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$88M	$71M	$49M	$38M	$55M	$46M	·
Net Income TTM	$-35M	$-43M	$-52M	$-65M	$-43M	$-65M	·
Market Cap	$56M	$4.45B	$3.54B	$3.57B	$3.26B	$10.71B	·
Enterprise Value	$37M	$4.43B	$3.52B	$3.53B	$3.22B	$10.66B	·
P/E	-1.5	-4.6	-57.5	-29.7	-67.0	·	·
P/S	0.6	62.4	72.1	93.4	59.8	235.1	·
P/B	-22.8	213.3	773.2	173.3	165.1	260.2	·
P / Tangible Book	·	·	·	·	·	831.8	·
P / Cash Flow	-2.4	-91.5	-154.9	-79.4	-115.4	-501.2	·
P / FCF	-2.4	-85.8	-77.3	-74.0	-106.9	-459.4	·
EV / EBITDA	-1.3	-128.3	-85.0	-69.7	-78.8	-464.8	·
EV / FCF	-1.6	-85.3	-76.8	-73.1	-105.9	-457.3	·
EV / Revenue	0.4	62.1	71.6	92.3	59.2	234.0	·
Earnings Yield	-68.7%	-21.7%	-1.7%	-3.4%	-1.5%	·	·

Income Statement 14

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$27M	$26M	$29M	$22M	$20M	$18M	$20M	$18M	$18M	$15M	$15M	$13M	$12M	$9M	$10M	$11M
R&D Expense	$3M	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$2M	$2M	$2M	$3M	$3M	$4M	$3M
SG&A Expense	$24M	$24M	$23M	$22M	$22M	$20M	$20M	$20M	$20M	$21M	$16M	$15M	$17M	$19M	$17M	$15M
Operating Expenses	$32M	$32M	$31M	$29M	$30M	$27M	$27M	$27M	$26M	$26M	$22M	$21M	$23M	$25M	$23M	$22M
Operating Income	$-5M	$-6M	$-2M	$-7M	$-10M	$-9M	$-7M	$-9M	$-8M	$-11M	$-7M	$-7M	$-11M	$-16M	$-14M	$-11M
Interest Expense	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$3M	$3M
Other Non-op	$97.0K	$385.0K	$-8M	$409.0K	$51.0K	$98.0K	$-8M	$374.0K	$-387.0K	$-64.0K	$-11M	$2.0K	$1.0K	$1.0K	$-6M	$-3M
Income Tax	$0	$0	$0	$0	$0	$0	·	$0	$0	$0	·	$0	$0	$0	·	$0
Net Income	$-7M	$-8M	$-4M	$-9M	$-11M	$-11M	$-8M	$-10M	$-11M	$-14M	$-9M	$-11M	$-13M	$-19M	$-20M	$-14M
EPS (Basic)	$-0.71	$-0.81	$-3.35	$-1.16	$-1.56	$-1.52	$-5.02	$-1.40	$-0.08	$-0.14	$-0.09	$-0.14	$-0.17	$-0.24	$-0.31	$-0.34
EPS (Diluted)	$-0.71	$-0.81	$-3.35	$-1.16	$-1.56	$-1.52	$-5.02	$-1.40	$-0.08	$-0.14	$-0.09	$-0.14	$-0.17	$-0.24	$-0.31	$-0.34
Shares (Basic)	10,296,000	9,656,000	·	7,500,000	7,333,000	7,300,000	·	7,315,000	127,168,000	97,166,000	·	79,709,000	78,506,000	77,765,000	·	40,448,000
Shares (Diluted)	10,296,000	9,656,000	·	7,500,000	7,333,000	7,300,000	·	7,315,000	127,168,000	97,166,000	·	79,709,000	78,506,000	77,765,000	·	40,448,000
EBITDA	$-5M	$-6M	·	$-7M	$-10M	$-9M	·	$-9M	$-8M	$-11M	·	$-7M	$-11M	$-16M	·	$-11M

Balance Sheet 26

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$30M	$26M	$19M	$17M	$21M	$18M	$26M	$31M	$42M	$11M	$26M	$20M	$17M	$25M	$43M	$15M
Receivables	$9M	$10M	$9M	$13M	$7M	$8M	$9M	$8M	$10M	$10M	$8M	$6M	$4M	$5M	$5M	$4M
Other Current Assets	$4M	$6M	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$7M	$6M	$3M	$4M	$5M	$5M	$4M
Current Assets	$44M	$41M	$33M	$33M	$32M	$30M	$39M	$44M	$58M	$28M	$40M	$29M	$25M	$35M	$53M	$24M
PP&E (Net)	$24M	$24M	$25M	$25M	$26M	$27M	$28M	$29M	$28M	$29M	$28M	$25M	$19M	$13M	$6M	$4M
PP&E (Gross)	$38M	$38M	$37M	$37M	$37M	$37M	$37M	$37M	$35M	$35M	$33M	$33M	$27M	$20M	$13M	$12M
Accum. Depreciation	$14M	$13M	$13M	$12M	$11M	$10M	$9M	$8M	$7M	$7M	$6M	$8M	$8M	$7M	$7M	$7M
Goodwill	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M
Intangibles	$3M	$3M	$4M	$4M	$5M	$5M	$6M	$6M	$7M	$7M	$8M	$8M	$9M	$9M	$10M	$10M
Other Non-current Assets	$6M	$8M	$8M	$8M	$7M	$7M	$7M	$7M	$7M	$6M	$7M	$7M	$7M	$6M	$6M	$6M
Total Assets	$95M	$95M	$87M	$89M	$88M	$86M	$97M	$103M	$116M	$87M	$99M	$87M	$78M	$81M	$93M	$63M
Accounts Payable	$2M	$4M	$3M	$4M	$3M	$3M	$2M	$3M	$2M	$3M	$3M	$3M	$4M	$2M	$2M	$2M
Accrued Liabilities	$10M	$8M	$11M	$10M	$10M	$7M	$10M	$9M	$8M	$8M	$8M	$7M	$7M	$6M	$8M	$7M
Short-term Debt	·	$2.0K	$6.0K	$11.0K	$16.0K	$18.0K	$21.0K	$29.0K	$37.0K	$45.0K	$51.0K	$50.0K	$50.0K	$50.0K	$49.0K	$14M
Current Liabilities	$15M	$14M	$17M	$18M	$15M	$13M	$14M	$13M	$18M	$31M	$33M	$33M	$28M	$22M	$23M	$37M
Capital Leases	$23M	$24M	$24M	$24M	$24M	$24M	$25M	$25M	$25M	$25M	$25M	$25M	$19M	$12M	$5M	$3M
Other Non-current Liabilities	$704.0K	$860.0K	$1M	$769.0K	$549.0K	$692.0K	$815.0K	$620.0K	$744.0K	$615.0K	$712.0K	$815.0K	$896.0K	$648.0K	$558.0K	$60.0K
Total Liabilities	$86M	$86M	$90M	$90M	$87M	$75M	$76M	$75M	$80M	$93M	$95M	$88M	$85M	$76M	$72M	$66M
Long-term Debt	$50M	$50M	$50M	$50M	$50M	$40M	·	$40M	$40M	$40M	·	$30M	$30M	$30M	·	$22M
Total Debt	·	$2.0K	·	$11.0K	$16.0K	$18.0K	·	$29.0K	$37.0K	$45.0K	·	$50.0K	$50.0K	$50.0K	·	$14M
Common Stock	$11.0K	$10.0K	$8.0K	$8.0K	$146.0K	$146.0K	$7.0K	$145.0K	$145.0K	$97.0K	$96.0K	$88.0K	$79.0K	$78.0K	$78.0K	$41.0K
Paid-in Capital	$522M	$515M	$495M	$492M	$486M	$485M	$483M	$482M	$480M	$428M	$424M	$409M	$392M	$391M	$388M	$344M
Retained Earnings	$-513M	$-506M	$-498M	$-494M	$-485M	$-474M	$-462M	$-454M	$-444M	$-433M	$-420M	$-410M	$-399M	$-386M	$-367M	$-347M
Stockholders' Equity	$9M	$9M	$-2M	$-2M	$1M	$11M	$21M	$28M	$36M	$-6M	$5M	$-1M	$-7M	$5M	$21M	$-3M
Liabilities + Equity	$95M	$95M	$87M	$89M	$88M	$86M	$97M	$103M	$116M	$87M	$99M	$87M	$78M	$81M	$93M	$63M
Shares Outstanding	10,549,890	10,107,219	8,253,053	7,954,541	146,584,110	146,443,460	7,274,578	145,465,941	145,149,630	97,159,448	96,235,883	88,315,802	78,610,663	77,979,376	77,614,358	41,185,532

Cash Flow 13

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$977.0K	$782.0K	$784.0K	$785.0K	$898.0K	$893.0K
Stock-based Comp	$820.0K	$1M	$1M	$1M	$1M	$972.0K	$1M	$2M	$1M	$3M	$1M	$954.0K	$1M	$2M	$2M	$1M
Amort. of Intangibles	$500.0K	$500.0K	$528.0K	$500.0K	$500.0K	$500.0K	$-992.0K	$2M	$1M	$500.0K	$-1M	$2M	$1M	$500.0K	$-1M	$2M
Operating Cash Flow	$-2M	$-10M	$778.0K	$-9M	$-7M	$-9M	$-4M	$-11M	$-19M	$-15M	$-12M	$-4M	$937.0K	$-8M	$-12M	$-10M
CapEx	$197.0K	$81.0K	$86.0K	$48.0K	$51.0K	$74.0K	$839.0K	$231.0K	$2M	$234.0K	$3M	$6M	$6M	$8M	$2M	$777.0K
Investing Cash Flow	$-254.0K	$-144.0K	$-104.0K	$-67.0K	$-95.0K	$-137.0K	$-884.0K	$-286.0K	$-2M	$-273.0K	$-3M	$-6M	$-6M	$-8M	$-2M	$-815.0K
Net Debt Issued	·	$-5.0K	·	·	·	$-7.0K	·	·	·	$-13.0K	·	·	·	$-12.0K	·	·
Stock Issued	$7M	$17M	$2M	·	·	·	$0	$0	$55M	$625.0K	$13M	·	·	·	$42M	$2M
Net Stock Activity	·	$17M	·	·	·	·	·	·	·	$625.0K	·	·	·	·	·	·
Financing Cash Flow	$6M	$17M	$2M	$5M	$10M	$97.0K	$-181.0K	$144.0K	$51M	$791.0K	$22M	$12M	$-2M	$-2M	$42M	$-2M
Net Change in Cash	$4M	$7M	$2M	$-4M	$3M	$-9M	$-5M	$-11M	$31M	$-15M	$6M	$2M	$-8M	$-18M	$28M	$-13M
Taxes Paid	$0	$0	·	$0	$0	$0	·	$0	$0	$0	·	$0	$0	$0	·	$0
Free Cash Flow	·	$-10M	·	·	·	$-9M	·	·	·	$-16M	·	·	·	$-15M	·	·

Profitability 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-20.1%	-24.3%	·	-32.4%	-48.5%	-50.9%	·	-47.3%	-46.0%	-74.4%	·	-53.2%	-92.0%	-180.8%	·	-95.5%
Net Margin	-27.1%	-30.5%	·	-40.0%	-57.3%	-61.8%	·	-56.5%	-60.3%	-91.9%	·	-81.2%	-112.5%	-206.5%	·	-123.3%
EBITDA Margin	-20.1%	-24.3%	·	-32.4%	-48.5%	-50.9%	·	-47.3%	-46.0%	-74.4%	·	-53.2%	-92.0%	-180.8%	·	-95.5%
ROA	-8.0%	-8.6%	·	-9.1%	-11.3%	-12.8%	·	-10.8%	-11.2%	-16.2%	·	-14.6%	-17.5%	-26.3%	·	-17.9%
ROE	-141.5%	-77.2%	·	-66.7%	-61.3%	-399.5%	·	-77.7%	-73.9%	2860.1%	·	503.5%	-3939.8%	-303.3%	·	-208.7%

Liquidity & Solvency 4

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	2.8	2.8	·	1.8	2.1	2.2	·	3.4	3.3	0.9	·	0.9	0.9	1.6	·	0.6
Quick Ratio	2.6	2.4	·	1.6	1.9	1.9	·	3.0	3.0	0.7	·	0.8	0.8	1.4	·	0.5
Debt / Equity	·	0.0	·	-0.0	0.0	0.0	·	0.0	0.0	-0.0	·	-0.0	-0.0	0.0	·	-4.9
Interest Coverage	-2.7	-3.1	·	-3.4	-5.1	-5.4	·	·	-4.3	-4.4	·	-3.0	-4.5	-6.8	·	-3.5

Efficiency 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.3	0.3	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.1	·	0.1
Receivables Turnover		3.2	3.0	·	2.1	2.3	2.0	·	2.6	2.5	2.0	·	2.6	2.5	2.1	·	3.1

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.87	$0.90	·	$-0.22	$0.01	$0.08	·	$0.19	$0.25	$-0.06	·	$-0.02	$-0.09	$0.06	·	$-0.07
Revenue / Share	$2.61	$2.65	·	$2.90	$0.14	$0.12	·	$0.12	$0.14	$0.15	·	$0.17	$0.15	$0.12	·	$0.27
Cash Flow / Share	·	$-1.05	·	·	·	$-0.06	·	·	·	$-0.16	·	·	·	$-0.10	·	·
Cash / Share	$2.84	$2.53	·	$2.09	$0.14	$0.12	·	$0.22	$0.29	$0.12	·	$0.22	$0.22	$0.32	·	$0.37
EPS (TTM)	$-6.03	$-6.88	·	$-9.26	$-9.50	$-8.02	·	$-1.71	$-0.45	$-0.54	·	$-0.86	$-1.06	$-1.29	·	$-1.73

Valuation (TTM) 11

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$103M	$96M	·	$80M	$77M	$74M	·	$66M	$61M	$55M	·	$44M	$42M	$41M	·	$36M
Net Income TTM	$-28M	$-32M	·	$-40M	$-41M	$-40M	·	$-44M	$-45M	$-47M	·	$-63M	$-66M	$-69M	·	$-58M
Market Cap	$238M	$147M	·	$60M	$827M	$1.83B	·	$5.18B	$4.44B	$2.78B	·	$2.91B	$1.93B	$2.90B	·	$1.05B
Enterprise Value	·	$121M	·	$43M	$806M	$1.81B	·	$5.15B	$4.40B	$2.77B	·	$2.89B	$1.92B	$2.88B	·	$1.05B
P/E	-3.7	-2.1	·	-0.8	-0.6	-1.6	·	-20.8	-68.0	-53.0	·	-38.4	-23.2	-28.8	·	-14.7
P/S	2.3	1.5	·	0.7	10.8	24.6	·	79.0	72.9	50.7	·	66.2	46.4	71.2	·	29.2
P/B	26.0	16.0	·	-34.9	726.5	165.5	·	185.9	122.5	-505.0	·	-2015.5	-276.5	637.5	·	-360.4
P / Tangible Book	·	·	·	·	·	·	·	810.7	309.6	·	·	·	·	·	·	·
P / Cash Flow	·	-14.4	·	·	·	-212.8	·	·	·	-181.5	·	·	·	-377.4	·	·
EV / Revenue	·	1.3	·	0.5	10.5	24.3	·	78.5	72.2	50.5	·	65.7	46.0	70.6	·	29.2
Earnings Yield	-26.7%	-47.4%	·	-122.6%	-168.4%	-64.2%	·	-4.8%	-1.5%	-1.9%	·	-2.6%	-4.3%	-3.5%	·	-6.8%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$88M	$71M	$49M	$38M	$55M
Operating Margin %	-31.5%	-48.4%	-84.2%	-132.4%	-75.1%
Net Income	$-35M	$-43M	$-52M	$-65M	$-43M
Diluted EPS	$-4.67	$-6.64	$-0.64	$-1.55	$-1.58

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debt / Equity	-0.0	0.0	0.0	0.0	0.0
Current Ratio	1.9	2.8	1.2	2.3	1.5
Quick Ratio	1.6	2.4	1.0	2.1	1.3

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-24M	$-52M	$-46M	$-48M	$-30M

Institutional owners (13F) 45 filers · $90.5M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 45

Value held $90.5M

New positions 10

Exited positions 5

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
10 (-13 vs prior Q)	5 (-3 vs prior Q)	14 (+7 vs prior Q)	13 (+11 vs prior Q)	+412K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
AIGH Capital Management LLC	$15,296,296	678,328	16.91%	Shares
Soleus Capital Management, L.P.	$13,213,353	585,958	14.60%	Shares
Telemark Asset Management, LLC	$11,045,531	489,824	12.21%	Shares
Aberdeen Group plc	$8,763,809	388,639	9.69%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$6,408,011	284,169	7.08%	Shares
ESSEX INVESTMENT MANAGEMENT CO LLC	$5,455,183	241,915	6.03%	Shares
Opaleye Management Inc.	$4,059,000	180,000	4.49%	Shares
MARSHALL WACE, LLP	$2,620,291	116,199	2.90%	Shares
PERCEPTIVE ADVISORS LLC	$2,451,049	108,694	2.71%	Shares
JANE STREET GROUP, LLC	$2,063,460	91,506	2.28%	Shares
TWO SIGMA INVESTMENTS, LP	$1,957,881	86,824	2.16%	Shares
Walleye Capital LLC	$1,678,780	74,447	1.86%	Shares
STEMPOINT CAPITAL LP	$1,578,500	70,000	1.74%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$1,526,702	67,657	1.69%	Shares
Trexquant Investment LP	$1,307,269	57,972	1.44%	Shares
VANGUARD GROUP INC	$1,306,538	192,138	1.44%	Shares
PERKINS CAPITAL MANAGEMENT INC	$1,006,136	44,618	1.11%	Shares
BlackRock, Inc.	$970,236	43,026	1.07%	Shares
BLAIR WILLIAM & CO/IL	$936,907	41,548	1.04%	Shares
VANGUARD FIDUCIARY TRUST CO	$901,075	39,959	1.00%	Shares
SEI INVESTMENTS CO	$841,002	37,295	0.93%	Shares
UBS Group AG	$674,426	29,908	0.75%	Shares
RENAISSANCE TECHNOLOGIES LLC	$646,012	28,648	0.71%	Shares
BANK OF AMERICA CORP /DE/	$602,942	26,738	0.67%	Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$587,089	26,035	0.65%	Shares
Quadrature Capital Ltd	$558,473	24,766	0.62%	Shares
STATE STREET CORP	$401,435	17,802	0.44%	Shares
Squarepoint Ops LLC	$354,238	15,709	0.39%	Shares
MILLENNIUM MANAGEMENT LLC	$324,810	14,404	0.36%	Shares
NORTHERN TRUST CORP	$312,520	13,859	0.35%	Shares
THOMPSON DAVIS & CO., INC.	$255,943	11,350	0.28%	Shares
Cannell & Spears LLC	$201,169	8,921	0.22%	Shares
Allworth Financial LP	$111,961	4,965	0.12%	Shares
Vanguard Global Advisers, LLC	$23,768	1,054	0.03%	Shares
CIBC Private Wealth Group LLC	$11,068	1,466	0.01%	Shares
BARCLAYS PLC	$7,058	313	0.01%	Shares
Pflug Koory, LLC	$5,638	250	0.01%	Shares
Fortitude Family Office, LLC	$3,856	171	0.00%	Shares
BNP PARIBAS FINANCIAL MARKETS	$2,661	118	0.00%	Shares
FMR LLC	$2,147	95	0.00%	Shares
MORGAN STANLEY	$1,376	61	0.00%	Shares
CITIGROUP INC	$1,308	58	0.00%	Shares
GSA CAPITAL PARTNERS LLP	$1,060	46,989	0.00%	Shares
JPMORGAN CHASE & CO	$1,024	43	0.00%	Shares
GILL CAPITAL PARTNERS, LLC	$293	13	0.00%	Shares

Activists & 5%+ owners 5 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
SCHULER JACK W, Jack W. Schuler Living Trust, Jack W. Schuler 2025 GRAT ×4 filings	Jan. 27, 2026	24.00%	Amendment	·	SEC
Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01, Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16, KFDI-B LLC, Lawrence T. Kennedy, Jr. ×4 filings	May 23, 2024	·	Initial filing	·	SEC
Jack W. Schuler, Jack W. Schuler Living Trust ×8 filings	May 23, 2024	·	Initial filing	·	SEC
Matthew Strobeck ×3 filings	April 9, 2024	·	Initial filing	·	SEC
John Patience, John Patience Living Trust dated 7/23/1993 ×3 filings	April 9, 2024	·	Initial filing	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 15 insiders · 7 officers · 8 directors

19

Insider	Role	Last activity	Shares owned	Buys 12m	Sells 12m	Net 12m
Scott Hutton	President & CEO	Feb. 20, 2026 M	48,767	0	4	$-64,263
Robin Harper Cowie	CFO, Sec'y & Treasurer	Feb. 20, 2026 M	16,231	0	4	$-19,132
Chris Vazquez	Chief Accounting Officer	Feb. 20, 2026 M	1,586	0	4	$-4,490
Kieran O'Kane	Chief Commercial Officer	Feb. 20, 2026 M	9,819	0	4	$-15,343
Gary Anthony Pestano	Chief Development Officer	Feb. 20, 2026 M	10,359	0	4	$-15,153
Ryan H Siurek	Chief Accounting Officer	May 8, 2023 M	40,268	0	0	$0
Robert William Georgantas III	Chief Scientific Officer	Nov. 21, 2022 A	38,114	0	0	$0
John Patience	Director	Sept. 30, 2026 M	26,743	0	0	$0
Lawrence T. Kennedy Jr	Director	Jan. 2, 2026 A	10,411,024	0	0	$0
Jean M. Franchi	Director	Jan. 2, 2026 A	108,140	0	0	$0
Matthew Strobeck	Director	Jan. 2, 2026 A	2,606,879	0	0	$0
Jon Faiz Kayyem	Director	Jan. 2, 2026 A	180,085	0	0	$0
Hany Massarany	Director	Jan. 2, 2026 A	310,135	0	0	$0
Charles M Watts	Director	March 31, 2025 M	421,705	0	0	$0
SCHULER JACK W	·	Aug. 12, 2026 P	555,810	6	0	$3,117,678

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 3 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
IWC · iShares Trust	0.03%	17,952 SH	Sept. 11, 2026	Daily
VXF · VANGUARD INDEX FUNDS	0.00%	72,031 SH	Aug. 19, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.00%	204,100 SH	Aug. 19, 2026	Daily

BDSX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 13 analysts BUY

Median target $39.00 +40.7%

3 23.1% Strong Buy

9 69.2% Buy

1 7.7% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

6 analysts · 2026-10-01

Mean target $37.33 +34.7%

← Below all targets Current price $27.72

Low$30.00 Mean$37.33 High$41.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
BDSX	$56M	-1.5	24.1%	-39.9%	5315.0%	·
SRTA	·	·	·	·	·	·
NRC	·	0.4	-4.0%	·	·	·
VMD	$282M	20.1	20.5%	5.5%	10.9%	57.5%
NAKA	$154M	-1.4	-33.0%	-2867.7%	-20.0%	·
CVS	$100.87B	57.1	7.8%	0.44%	2.4%	·

Latest News Recent headlines mentioning this company

23

Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions Yahoo Finance · 4 months, 1 week ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

BDSX Biodesix, Inc. - Common Stock